Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

CD20, CD22, CD23, but Not CD37 Expression on CD19 + B-Cells Is Altered by Exogenous Factors in a Sub-Population of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) Patients,

Robin R Frank, BS, Sucheta Jagan, MS, Laura A Paganessi, MA, Melissa L Larson, M.D., Reem Karmali, MD, Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Kent W Christopherson, II, PhD

Blood (2011) 118 (21): 3685.

https://doi.org/10.1182/blood.V118.21.3685.3685

Published: 2011

Journal Articles

Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Exhibit Altered Cytokine Protein Levels in Peripheral Blood Serum

Laura A Paganessi, MA, Robin R Frank, BS, Sucheta Jagan, MS, Reem Karmali, MD, Yan Li, Youping Deng, Cristina L Fhied, Jeffrey A Borgia, PhD, Melissa L Larson, M.D., Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Kent W Christopherson, II, PhD

Blood (2011) 118 (21): 2646.

https://doi.org/10.1182/blood.V118.21.2646.2646

Published: 2011

Journal Articles

Cytokine Treatment of CD34 + Cord Blood Cells with G-CSF, GM-CSF, or SCF During 48 Hours of Ex Vivo Culture Alters CD26/DPPIV Peptidase Activity and Subsequent Engraftment Into NSG Immunodeficient Mice.

Laura A Paganessi, MA, Lydia Luy Tan, BS, Sucheta Jagan, MS, Robin Frank, BS, Antonio M. Jimenez, MD, Elizabeth Shima Rich, MD, PhD, Sunita Nathan, MD, John Maciejewski, MD, PhD, Henry C. Fung, FRCP, MD, Kent W. Christopherson, II, PhD

Blood (2010) 116 (21): 1460.

https://doi.org/10.1182/blood.V116.21.1460.1460

Published: 2010

Journal Articles

CD26 Inhibition Preferentially Enhances In Vitro Migration of G-CSF + Plerixafor (AMD3100) Mobilized PB as Compared to G-CSF Mobilized PB In Multiple Myeloma Autografts.

Eun-Sun Yoo, MD, PhD, Sucheta Jagan, MS, Sridevi Palaparthy, MBA, MS, Mary A Enriquez, RN, ANP, Karen Samuels, RN, MS, NP-C, Sarah Walters, RN, MSN, GNP-BC, APN, Elizabeth Mieras, MMS, PA-C, Laura A Paganessi, MA, Chu-Myong Seong, MD, Elizabeth Shima Rich, MD, PhD, Henry C. Fung, FRCP, MD, Kent W. Christopherson, II, PhD

Blood (2010) 116 (21): 3714.

https://doi.org/10.1182/blood.V116.21.3714.3714

Published: 2010

Journal Articles

Gain of CD20 Target Cell Surface Receptor Expression During Serum-Free Ex Vivo Culture of CD19 + CD5 + B-Cells In a Sub-Population of Early Stage (Rai 0/1) Chronic Lymphocytic Leukemia Patients

Robin Frank, BS, Hugo Jimenez, Sucheta Jagan, MS, Lydia Luy Tan, BS, Laura A Paganessi, MA, Melissa L Larson, MD, Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Kent W Christopherson, II, PhD

Blood (2010) 116 (21): 2000.

https://doi.org/10.1182/blood.V116.21.2000.2000

Published: 2010

Journal Articles

Abnormally High Levels of Circulating CD34 + CD38 − , CD34 + CD38 + , and CD10 + Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Suggest the Presence of Additional Therapeutic Target Cells.

Kent W. Christopherson, PhD, Laura A. Paganessi, MA, Darilyn R. Rhoades, RN, Hortense M. Dillon, CMA, Sefer Gezer, MD, Melissa L. Larson, MD, Henry C. Fung, MD, Stephanie A. Gregory, MD

Blood (2007) 110 (11): 4711.

https://doi.org/10.1182/blood.V110.11.4711.4711

Published: 2007

NARROW

CD20, CD22, CD23, but Not CD37 Expression on CD19 + B-Cells Is Altered by Exogenous Factors in a Sub-Population of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) Patients,

Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Exhibit Altered Cytokine Protein Levels in Peripheral Blood Serum

Cytokine Treatment of CD34 + Cord Blood Cells with G-CSF, GM-CSF, or SCF During 48 Hours of Ex Vivo Culture Alters CD26/DPPIV Peptidase Activity and Subsequent Engraftment Into NSG Immunodeficient Mice.

CD26 Inhibition Preferentially Enhances In Vitro Migration of G-CSF + Plerixafor (AMD3100) Mobilized PB as Compared to G-CSF Mobilized PB In Multiple Myeloma Autografts.

Gain of CD20 Target Cell Surface Receptor Expression During Serum-Free Ex Vivo Culture of CD19 + CD5 + B-Cells In a Sub-Population of Early Stage (Rai 0/1) Chronic Lymphocytic Leukemia Patients

Abnormally High Levels of Circulating CD34 + CD38 − , CD34 + CD38 + , and CD10 + Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Suggest the Presence of Additional Therapeutic Target Cells.

Email alerts

ASH Publications

American Society of Hematology

CD20, CD22, CD23, but Not CD37 Expression on CD19 + B-Cells Is Altered by Exogenous Factors in a Sub-Population of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) Patients,

Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Exhibit Altered Cytokine Protein Levels in Peripheral Blood Serum

Cytokine Treatment of CD34 + Cord Blood Cells with G-CSF, GM-CSF, or SCF During 48 Hours of Ex Vivo Culture Alters CD26/DPPIV Peptidase Activity and Subsequent Engraftment Into NSG Immunodeficient Mice.

CD26 Inhibition Preferentially Enhances In Vitro Migration of G-CSF + Plerixafor (AMD3100) Mobilized PB as Compared to G-CSF Mobilized PB In Multiple Myeloma Autografts.

Gain of CD20 Target Cell Surface Receptor Expression During Serum-Free Ex Vivo Culture of CD19 + CD5 + B-Cells In a Sub-Population of Early Stage (Rai 0/1) Chronic Lymphocytic Leukemia Patients

Abnormally High Levels of Circulating CD34 + CD38 − , CD34 + CD38 + , and CD10 + Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Suggest the Presence of Additional Therapeutic Target Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only